Polen: BD Aiming For Higher Growth Spaces And More Tuck-Ins
Executive Summary
BD stressed the continued pursuit of an innovation-driven growth strategy as it announced fiscal 2021 sales of $20bn spurred by its pandemic response effort.
Topics
- Subjects
- Commercial
- Sales & Earnings
- Device Areas
- In Vitro Diagnostics
- Diabetic Care
- Durable Medical Equipment
- Gynecology & Urology
- Surgery
- Industries
- Medical Device
Latest Headlines
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
MT144689
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.
All fields are required.
MT144689
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.